Immunogenicity of a fourth dose of Haemophilus influenzae type b (Hib) conjugate vaccine and antibody persistence in young children from the United Kingdom who were primed with acellular or whole-cell pertussis component-containing Hib combinations i
about
Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccUpdated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunityNaturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in MaliThe effectiveness of conjugate Haemophilus influenzae type B vaccine in The Gambia 14 years after introduction.Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.A model for the regulation of follicular dendritic cells predicts invariant reciprocal-time decay of post-vaccine antibody response.Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b.A review of Haemophilus influenzae disease in Europe from 2000-2014: challenges, successes and the contribution of hexavalent combination vaccines.
P2860
Q33613482-939784FE-E33D-4C5A-823F-AFC3332AD59CQ33825722-44FB426B-F516-477E-8F8C-35DDF2390AE7Q36005810-099F53D3-3DA0-4E88-B3F6-2AA05814C3D9Q37272305-C0C8375C-69E9-446A-B6D3-256F4780C457Q37878485-6A338A75-CB61-4C2C-976F-C9D8548341E8Q39447300-5E5D7D29-D16D-4DE1-B626-304548E621C0Q41106547-74459675-E5DF-4AB1-866E-E731D9D53D91Q47877094-96F30FE8-5326-4968-B71E-2C1CC6B6798B
P2860
Immunogenicity of a fourth dose of Haemophilus influenzae type b (Hib) conjugate vaccine and antibody persistence in young children from the United Kingdom who were primed with acellular or whole-cell pertussis component-containing Hib combinations i
description
im Oktober 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2007
@uk
name
Immunogenicity of a fourth dos ...... -containing Hib combinations i
@en
Immunogenicity of a fourth dose of Haemophilus influenzae type b
@nl
type
label
Immunogenicity of a fourth dos ...... -containing Hib combinations i
@en
Immunogenicity of a fourth dose of Haemophilus influenzae type b
@nl
prefLabel
Immunogenicity of a fourth dos ...... -containing Hib combinations i
@en
Immunogenicity of a fourth dose of Haemophilus influenzae type b
@nl
P2093
P2860
P356
P1476
Immunogenicity of a fourth dos ...... -containing Hib combinations i
@en
P2093
Annette Crowley-Luke
David Gelb
Elizabeth Miller
Jo Southern
Nick Andrews
Rhonwen Morris
P2860
P304
P356
10.1128/CVI.00191-07
P407
P577
2007-10-01T00:00:00Z